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In a retrospective study conducted at the University of Alabama 
at Birmingham, the University of Michigan, and the Mayo Clinic, 
185 patients with previously untreated FIG0 stage IB and IIA 
squamous cell carcinoma of the cervix were found to have nodal 
metastasis at the time of radical hysterectomy and pelvic lymph- 
adenectomy. Of these patients, 103 received adjuvant pelvic ir- 
radiation. Cancer recurred in 76 patients; the median time to 
recurrence was 3.1 years. The prognostic significance of patient 
age, clinical stage, lesion diameter, number and location of nodal 
metastases, and use of adjuvant radiation therapy was determined 
by multivariate analysis. Only patient age (P = 0.0006), lesion 
diameter (P < O.OOOl), and number of nodal metastases (P = 
0.0004) were noted to be significant factors in determining overall 
survival. Rates of recurrence were also related to these factors. 
Employment of these significant variables led to identification of 
four risk groups. In general, patients with small cervical lesions 
(diameter < 1 cm) and no more than two nodes with metastases 
fell into the low-risk category; those patients with large cervical 
lesions (diameter > 4 cm) and more than two involved nodes fell 
into the high-risk category. All other patients were categorized 
into intermediate-risk groups. Ten-year survival was 92% in the 
low-risk group (n = 13), 70% in the low-intermediate-risk group 
(n = 66), 56% in the high-intermediate-risk group (n = 66), 
and 13% in the high-risk group (n = 20). This risk group clas- 
sification identifies subgroups of early-stage cervical carcinoma 
patients found to have nodal metastasis at the time of radical 
hysterectomy that warrant appropriately selected adjuvant ther- 
apy. 0 1989 Academic press, Inc. 
INTRODUCTION 
Of all histopathologic features, the presence of lymph 
node metastasis has been described as perhaps the most 
’ Presented at the 1989 Annual Meeting of the American College of 
Obstetrics and Gynecology. 
significant prognostic factor in those patients undergoing 
radical hysterectomy for early-stage cervical carcinoma 
[l, p. 148; 2,3]. Although adjuvant pelvic irradiation is 
employed by many clinicians in this particular situation, 
controversy exists over the value of such treatment in 
terms of overall survival [4-IO]. Systemic therapy has 
been advocated by some [I, p. 148; 11,121, yet no pro- 
spective randomized studies have been reported. Long- 
term survival occurs in many patients even in the ab- 
sence of adjuvant treatment [13]. The purpose of this 
report is to identify the patients with early-stage squa- 
mous cell carcinoma of the cervix found to have pelvic 
node metastasis at the time of radical hysterectomy and 
lymphadenectomy who are at significant risk for tumor 
recurrence and are therefore potential candidates for ad- 
juvant therapy. 
MATERIALS AND METHODS 
A retrospective review of all patients with early-stage 
squamous carcinoma of the cervix who were treated by 
radical hysterectomy and pelvic lymphadenectomy was 
conducted at the University of Alabama at Birmingham 
(UAB), the University of Michigan (UM), and the Mayo 
Clinic (MC). Nodal metastasis was identified in 185 pa- 
tients”8 from UAB, 42 from UM, and 95 from MC. 
The medical records of these patients were reviewed with 
special emphasis on the clinicopathologic findings at the 
time of initial presentation and treatment and, when ap- 
plicable, at the time of tumor recurrence. Current follow- 
up status was obtained by review of the patient record, 
by written or telephone correspondence, or by review 
of the death certificate. 
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The median age of the 185 patients found to have nodal 
metastasis at the time of radical hysterectomy was 42 
years. FIG0 stage IB was documented in 150 patients; 
the remaining 35 patients were assigned FIG0 stage IIA. 
Median tumor diameter was 3.0 cm, with a range of 0.5 
to 9.5 cm. The total number of metastatically involved 
nodes ranged from 1 to 35: 95 patients had metastasis 
to a single node and only one patient had more than 12 
involved nodes. Bilateral pelvic nodal involvement was 
observed in 47 patients. Paraaortic nodes were sampled 
in 137 patients; only 5 patients were found to have me- 
tastasis to the paraaortic nodal region. 
Postoperative adjuvant pelvic irradiation was admin- 
istered to 103 of 185 patients (56%). The median midplane 
dose of pelvic irradiation was 5000 cGy, with 75% of 
patients treated with adjuvant pelvic irradiation receiving 
greater than or equal to 5000 cGy. Median follow-up time 
was 4.7 years. Recurrence was documented in 76 patients 
with a median disease-free interval of 3.1 years. Isolated 
pelvic failures occurred in 27 patients; 37 patients had 
isolated distal recurrence. Six patients had both pelvic 
and distal recurrence: the site of recurrence was not 
specified in 6 of the 76 patients with recurrence. Of the 
76 patients who had recurrence, 43 had received adjuvant 
pelvic irradiation postoperatively. 
The prognostic significance of patient age, clinical 
stage, tumor diameter, number and location of nodal 
metastases, and use of adjuvant radiation therapy was 
studied by univariate and multivariate analysis and ex- 
pressed in terms of both survival and recurrence. The 
survival curves were calculated using the method of Kap- 
lan and Meier, and the log-rank test was employed to 
determine the level of significance. With postoperative 
adjuvant treatment employed as the stratification vari- 
able, the multivariate analysis was performed using the 
rank regression procedure described by Kalbfleisch and 
Prentice [14]. x2 analysis was also utilized to compare 
recurrence and survival rates. A result was deemed sig- 
nificant when P was less than 0.05. 
RESULTS 
The results of our analysis demonstrated no significant 
institutional differences in overall survival. When ana- 
lyzed separately as a single factor, patient age (P < 
0.0001) and tumor diameter (P < 0.0001) were found to 
significantly correlate with patient survival (Figs. 1 and 
2). Clinical stage was also noted to significantly correlate 
with patient survival: 5-year survival was 75% in FIG0 
stage IB patients and 62% in FIG0 stage IIA patients 
(P = 0.0096). Although there was no significant asso- 
ciation of survival with the number of nodal metastases, 
there was a trend toward poorer survival in those patients 
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FIG. 1. Early-stage cancer of the cervix with nodal metastasis: 
survival according to age group. 
was no significant association of survival with unilateral 
versus bilateral nodal metastasis. Four of five patients 
with metastasis to periaortic nodes died, three of disease 
and one of complications related to adjuvant radiother- 
apy. The significance of metastasis to nodes above the 
level of the common iliac vessels was difficult to delin- 
eate in this study due to the small number of patients 
with metastasis to that region. There was no survival 
benefit to adjuvant radiation therapy: the significance of 
this finding has been delineated in a matched, controlled 
study described elsewhere [4]. 
In the multivariate analysis, when all factors were si- 
multaneously assessed, the number of nodal metastases 
(P = 0.0004) proved to be a significant variable in de- 
termining survival, in addition to patient age (P = 0.006) 
and tumor diameter (P < 0.0001) (Table I). Clinical stage 
was not a significant factor in determining survival after 
adjustment for other factors. Similar clinico-pathologic 
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FIG. 2. Early-stage cancer of the cervix with nodal metastasis: 
survival according to tumor diameter. 
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TABLE 1 TABLE 3 
Prognostic Factor Analysis Definition of Risk Groups” 
Univariate Multivariate 
analysis analysis” 
Factor X2 P X2 P 
Age 15.7 <O.OOOl 11.8 0.006 
Tumor diameter 22.0 <0.0001 22.0 <0.0001 
Clinical stage 6.7 0.0096 0.2 0.6790 
Number of nodes with 
metastasis 2.5 0.1139 12.4 0.0004 
Bilateral vs 
unilateral nodes 
with metastasis 1.1 0.2973 2.2 0.1355 
” Based on the rank regression analysis with stratification for treat- 
ment (surgery only vs surgery and radiation). 
Lesion size 
Number of nodes 
with metastasis < 1 cm 1.1-4 cm > 4 cm 
G2 LR IRI IR2’ 
>2 IRI IR2 HR 
” LR, low risk; IRI, low intermediate risk; IR2, high intermediate 
risk; HR, high risk. 
’ This group includes only patients under age 60. All patients 60 
years and older with cervical lesions larger than 4 cm in diameter and 
with two or fewer involved nodes were classified in the high-risk group. 
recurrence. In univariate analysis, patient age (P = 
0.0049), tumor diameter (P < O.OOOl), and number of 
nodal metastases (P = 0.0023) were significant factors 
in determining the rate of recurrence; these factors re- 
mained significant after adjustment for other variables 
(Table 2). 
risk group, and, obviously, the low-risk and high-risk 
groups (P < 0.0001). Recurrence rates were 8% in the 
low-risk group, 29% in the low-intermediate-risk group, 
53% in the high-intermediate-risk group, and 80% in the 
high-risk group (P < 0.0001). 
DISCUSSION 
By employment of these independently significant clin- 
ical variables, risk groups could be formulated. Patients 
could be categorized into groups of low, low-interme- 
diate, high-intermediate, and high risk. The character- 
istics of each group are demonstrated in Table 3. The 
number of patients in each group receiving adjuvant ra- 
diotherapy is given in Table 4. Ten-year survival was 
92% in the low-risk group (n = 13), 70% in the low- 
intermediate-risk group (n = 66), 56% in the high-inter- 
mediate-risk group (n = 66), and 13% in the high-risk 
group (n = 20) (Fig. 3). There was a significant difference 
in survival rates between the low-risk and intermediate- 
risk groups, the intermediate-risk groups and the high- 
TABLE 2 
Recurrence Rates According to Prognostic Clinical Variables 
Clinical variables Number of patients Recurrence rate (%) P” 
Age (years) 
20-49 130 35 
50-69 49 53 
270 6 83 0.008 
Tumor diameter (cm) 
s 1.0 17 18 
1.1-2.0 29 31 
2.1-4.0 69 38 
4.1-6.0 45 58 
> 6.0 I5 67 0.006 
Number of nodes with metastasis 
1 95 32 
2 33 42 
>2 47 62 0.003 
a Determined by multivariate analysis. 
Carcinoma metastatic to regional lymph nodes is a 
poor prognostic indicator in patients undergoing radical 
hysterectomy for early-stage squamous cell carcinoma 
of the cervix. Overall survival in this group of patients 
is stated to be 50 to 60% [2,3,15]. In an effort to delineate 
risk groups in patients with cervical carcinoma found to 
have pelvic node metastases, the prognostic significance 
of several nodal characteristics has been investigated. A 
summary of several reports regarding the prognostic sig- 
nificance of number of nodal metastases, metastasis to 
nodes in the region of the common iliac vessels and 
above, and bilateral pelvic nodal metastasis as opposed 
to unilateral involvement is included in Table 5. Most 
of these reports conclude that extensive nodal metastasis 
or metastasis to the nodes in the region of the common 
iliac vessels and above are poor prognostic nodal char- 
acteristics. Whether bilateral nodal metastasis connotes 
a less favorable prognosis relative to unilateral involve- 
ment remains unresolved. Other nodal characteristics 
that have been suggested as prognostic indicators include 
dimensions of the metastatically involved nodes and re- 
sectability of the involved nodes [22,23]. 
TABLE 4 
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FIG. 3. Early-stage cancer of the cervix with nodal metastasis: 
survival according to risk group. 
Too little attention has been focused on the prognostic 
significance of characteristics of the primary cervical le- 
sion in patients with early-stage cervical cancer found 
to have nodal metastasis at the time of radical hyster- 
ectomy. Many of these characteristics, i.e., lesion di- 
ameter, depth of invasion, lymph-vascular space inva- 
sion, and parametrial extension, are known to be 
associated with a high risk of nodal metastasis and with 
a high rate of tumor recurrence even in the absence of 
nodal metastasis [12,19,24-261. In a study of 71 early- 
stage cervical carcinoma patients found to have nodal 
metastasis at the time of radical hysterectomy, Fuller et 
al. [21] noted clinical stage, cervical lesion diameter, 
tumor histology, and parametrial or uterine extension to 
be prognostically significant tumor characteristics. Spe- 
cifically, 20 of 44 patients (45%) with cervical carcinoma 
lesions 3 cm or larger recurred as opposed to 9 of 26 
patients (35%) with lesions smaller than 3 cm; however, 
no statistical analysis was provided. In a study of 25 
patients with nodal metastases, Chung et al. [12] noted 
an extremely high rate of both local and distant recur- 
rences in those patients with bulky primary tumors, but 
no statistical correlation according to cervical lesion di- 
ameter in patients with nodal metastasis was provided. 
TABLE 5 
Prognostic Characteristics of Metastatically Involved Nodes: Review of the Literature 
Author 
Pilleron et a/. [15] 
Hsu et a/. [16] 
Martimbeau et al. [I71 
Tanaka et al. (181 
Piver and Chung [19] 
Morrow [5] 
Webb and Symmonds [2] 
Kim ef a/. [20] 
Fuller et al. [21] 






























































” As determined by univariate analysis. 
’ S, significant; NS, not significant; NA, not analyzed, 
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No other report to date has investigated the prognostic 
significance of the aforementioned characteristics of the 
primary cervical lesion in patients found to have nodal 
metastasis at the time of radical hysterectomy. 
In this study, we have investigated the prognostic sig- 
nificance of characteristics of both the nodal metastases 
and the primary cervical lesion. The number of metas- 
tatically involved nodes and the diameter of the primary 
lesion were the histopathologic features that readily iden- 
tified prognostically significant risk groups. These two 
factors reflect the impact of both the primary lesion and 
the secondary site tumor burden in determining prog- 
nosis. Our data would suggest that the patients with small 
tumor dimensions (diameter < 1.0 cm) and with one to 
two involved nodes have an excellent prognosis and are 
adequately treated with radical hysterectomy and pelvic 
lymphadenectomy. Adjuvant pelvic irradiation is prob- 
ably unnecessary in this group. Conversely, patients with 
large tumor dimensions (diameter > 4.0 cm) and more 
than two involved nodes are at high risk for tumor re- 
currence and have compromised survival. This high-risk 
group, therefore, warrants aggressive adjuvant treatment 
with systemic therapy in the presence or absence of 
pelvic radiotherapy. For those patients designated as 
being at intermediate risk, adjuvant pelvic irradiation 
may be beneficial in affording local pelvic tumor control 
but, as previously stated, the value of such adjuvant 
treatment in terms of overall survival remains unresolved 
[4-101. 
Confirming the observations of Fuller et al. [21], the 
present study demonstrated an inverse correlation be- 
tween survival and age in patients found to have lymph 
node metastasis at the time of radical hysterectomy. The 
significance of age in patients with cervical carcinoma 
has been extensively investigated but, nevertheless, re- 
mains unresolved [1, p. 1231. Our results might suggest 
that the elderly patient with large tumor dimensions and 
multiple nodal metastases is either more immunologically 
compromised or less able to tolerate aggressive adjuvant 
or salvage therapy than younger patients. 
In conclusion, this report is the initial assessment em- 
ploying a multivariate analysis of the prognostic signif- 
icance of the characteristics of both the primary cervical 
lesion and the regional lymph nodes in patients with 
early-stage squamous cervical carcinoma found to have 
nodal metastasis at the time of radical hysterectomy. 
These analyses have facilitated the identification of spe- 
cific groups of patients at high risk for tumor recurrence 
and poor overall survival who warrant innovative ad- 
juvant therapy. Further investigation of the significance 
of other clinical histopathologic risk factors in discrim- 
inating between risk groups and future controlled pro- 
spective studies of adjuvant therapy in both intermediate- 
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